BioSpace News Archive

Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the Thermo Scientific MAS Omni Infectious Disease quality control sets for monitoring serological assays for analytes such as HIV 1&2, Hepatitis B & C virus, Syphilis and HTLV I/II.

Ipsen presents Phase I/II clinical data evaluating liposomal irinotecan (Onivyde ® ) as an investigational first-line combination treatment for metastatic pancreatic cancer at the ESMO World Congress on Gastrointestinal Cancer Ipsen has initiated the NAPOLI-3 Phase III clinical study (NCT04083235) comparing the safety and efficacy of liposomal irinotecan + 5-fluorouracil/leucovorin (5-FU/LV) + oxaliplatin (OX) (NALIRIFOX) to gemcitabine + nab-paclitaxel in the f

Battelle has directed philanthropic giving to the Columbus Urban League, Equal Justice Initiative and United Negro College Fund in the form of $100,000 gifts to each.

Medical Tourism Association partners with Korea Tourism Organization as South Korea extends high complexity medical services to international patients at a pivotal COVID-19 transition point.

Signpost Six, a Dutch insider risk management firm, and Nick Eftimiades, founder of Shinobi Enterprises and a leading U.S. expert on (Chinese) espionage, will be conducting a one-hour webinar to discuss the current state of insider risk in the biotechnology sector on Tuesday, 14 July, at 11:00 EST (17:00 CET).

Zomedica Pharmaceuticals Corp. (NYSE American: ZOM), (“Zomedica” or the “Company”), a veterinary diagnostic company, announced today that it has commenced a public offering of its common shares, together with warrants to purchase its common shares.

Montana Business Produced 2019 Revenue of $10.4 Million

The Stanford Medicine physician and other renowned experts will deliver critical insights and perspectives on the management of lung cancer.

Verdosome, a privately-held molecular testing laboratory with principal operations in Wheat Ridge, Colorado, announced today the introduction of its COVID Pod™ technology for the testing of SARS-CoV-2, the virus that causes COVID-19